CN Patent

CN102231990A — N-[2，4-双(1，1-二甲基乙基)-5-羟基苯基]-1，4-二氢-4-氧代喹啉-3-甲酰胺的药物组合物和其给药

Assigned to Vertex Pharmaceuticals Inc · Expires 2011-11-02 · 15y expired

What this patent protects

本发明涉及包含N-[2，4-双(1，1-二甲基乙基)-5-羟基苯基]-1，4-二氢-4-氧代喹啉-3-甲酰胺的固体分散体的药物组合物、本发明药物组合物的制备方法和本发明药物组合物的给药方法。

USPTO Abstract

本发明涉及包含N-[2，4-双(1，1-二甲基乙基)-5-羟基苯基]-1，4-二氢-4-氧代喹啉-3-甲酰胺的固体分散体的药物组合物、本发明药物组合物的制备方法和本发明药物组合物的给药方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102231990A
Jurisdiction
CN
Classification
—
Expires
2011-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.